Recombinant SARS-CoV-2 Fusion Protein Vaccine (V-01) Booster Study

NCT05096832 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

10381

Enrollment

INDUSTRY

Sponsor class

Conditions

COVID-19 Pandemic

Interventions

BIOLOGICAL: Recombinant SARS-CoV-2 Fusion Protein Vaccine (V-01)
BIOLOGICAL: Blank Preparation of Recombinant SARS-CoV-2 Fusion Protein Vaccine (V-01)

Sponsor

Livzon Pharmaceutical Group Inc.